Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression

Journal of Psychiatry and Neuroscience

Volumn 27, Issue 4, 2002, Pages 281-290

  Segal, Zindel ^a   Vincent, Pierre ^a   Levitt, Anthony ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antidepressive agents; Behavioral symptoms; Cognitive therapy; Combined modality therapy; Depressive disorder; Drug therapy; Psychiatric status rating scales; Psychotherapy; Recurrence; Remission induction; Treatment outcome

Indexed keywords

IMIPRAMINE; NEFAZODONE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; HEALTH CARE COST; HUMAN; MAINTENANCE THERAPY; MONOTHERAPY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RECURRENT DISEASE; RELAPSE; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS; TREATMENT OUTCOME;

EID: 0036655376     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Treatment of depression and the functional capacity to work
2. Three-year outcomes for maintenance therapies in recurrent depression
3. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in outpatients with recurrent depression
4. Compliance with pharmacology in mood disorders
5. The role of the primary physician in patients' adherence to antidepressant therapy
6. Cognitive therapy and pharmacotherapy for depression: Singly and in combination
7. Prevention of recurrent depression with cognitive behavioral therapy
8. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years
9. Interpersonal psychotherapy (IPT) and drugs in the treatment of depression
10. A comparison of nefazodone, the cognitive behavioural-analysis system of psychotherapy and their combination therapy for the treatment of chronic depression
11. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy
12. The efficacy of cognitive therapy in depression: A treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination
13. A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both
14. Treatment of depression in general practice
15. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations
16. Economic aspects of nefazodone, CBASP, and their combination for the treatment of chronic depression
17. Differential relapse following cognitive therapy and pharmacotherapy for depression
18. Cognitive therapy and pharmacotherapy: Singly and together in the treatment of depression
19. Cognitive therapy and pharmacotherapy for depression: Sustained improvement over one year
20. A cost-effectiveness analysis of cognitive behavior therapy and fluoxetine (Prozac) in the treatment of depression
21. Prevention of relapse in residual depression by cognitive therapy
22. Interpersonal psychotherapy and antidepressant medication: Evaluation of a sequential treatment strategy in women with recurrent major depression
23. Cognitive behavioural treatment of residual symptoms primary major depressive disorder
24. Four-year outcome for cognitive behavioural treatment of residual symptoms primary major depressive disorder
25. Six-year outcome for cognitive behavioral treatment of residual symptoms primary major depressive disorder